← Leaderboards
John Martin Magenau
University Of Michigan At Ann Arbor
$982,800
Attributed
$982,800
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.6K · FY2017–21$200K$150K$100K$50K$0
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$982,800 · 1
By mechanism
K23$982,800 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Pavan Reddy$35,237,005
- Jonathan S Bromberg$26,279,150
- James J. Moon$14,172,333
- Malini Raghavan$15,429,161
- Sung Won Choi$6,756,881
Others in their field
Other Emerging Leaders on “Adopted”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- April Brinkoetter · Hungry Heart Media, Inc.$57,302,265
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$28,235,661
- Kathleen Maletic Neuzil · Emory University$26,258,144
- Abraham Aizer Brody · New York University School Of Medicine$24,513,574
Research focus
AdoptedAcute Myelocytic LeukemiaAntigen-Presenting CellsAntigensAllogenicAntigen TargetingBiobankBiologyCareer DevelopmentCellsClinicClinical InvestigationClinical ResearchClinical TranslationClinical TrialsConditioningCross PresentationDesignDisorder Later Incidence PreventionEffectivenessEnvironmentEthicsExperimental ModelsFda Approved
Grant awards (5)
Targeting antigen cross-presentation to enhance anti-leukemic responses after allogeneic transplantation$196,560
K23 · FY2021 · AI · contact PI
Targeting antigen cross-presentation to enhance anti-leukemic responses after allogeneic transplantation$196,560
K23 · FY2020 · AI · contact PI
Targeting antigen cross-presentation to enhance anti-leukemic responses after allogeneic transplantation$196,560
K23 · FY2019 · AI · contact PI
Targeting antigen cross-presentation to enhance anti-leukemic responses after allogeneic transplantation$196,560
K23 · FY2018 · AI · contact PI
Targeting antigen cross-presentation to enhance anti-leukemic responses after allogeneic transplantation$196,560
K23 · FY2017 · AI · contact PI